Hope we don't get the same old tired spiel.If this stock is going to re rate, we need to attract new money. The story is good, but it needs to be told in a more convincing way.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025